Laura Dorwart is a health journalist with expertise in disability rights, mental health, and pregnancy-related conditions. She has written for publications like SELF, The New York Times, VICE, and The Guardian.
Patricia Horosz, PharmD, is an inpatient clinical pharmacist. She co-heads the Antibiotic Stewardship program and the Pharmacy and Therapeutics Committee at the hospital.
Antidepressants are prescription medications typically used to treat depression and other mental health conditions.
Clinical depression, also called major depressive disorder (MDD), involves ongoing feelings of sadness, emptiness, apathy, and worthlessness. It can also cause symptoms like fatigue, problems with sleep, appetite changes, irritability, and chronic pain.
Antidepressants help reduce these symptoms by balancing the level of certain neurotransmitters (chemical messengers) in the brain. Estimates suggest that about 13% of U.S. adults take antidepressants. Women are over twice as likely as men to take antidepressants regularly.
This article discusses antidepressants, including types, side effects, uses, effectiveness, and more.
There are several different types of antidepressants. Each one acts on the brain differently to reduce the symptoms of depression. Learn more about the most common types of antidepressants and how they work.
Serotonin and noradrenaline reuptake inhibitors (SNRIs) are popular antidepressants that increase the level of two different neurotransmitters—serotonin and noradrenaline —in the brain.
Serotonin is involved with mood, memory, learning, and emotion. Noradrenaline, also called norepinephrine, helps you manage stress and remain calm during a crisis.
SNRIs work by inhibiting the reuptake of serotonin and noradrenaline by the neurons that release them. They stop these neurotransmitters from being reabsorbed. This increases the amount of serotonin and noradrenaline available in your brain.
Selective serotonin reuptake inhibitors (SSRIs) are the most common type of antidepressants. SSRIs work by blocking the reuptake of serotonin in the brain. This can help improve mood and motivation, relieving depression symptoms and bringing about a greater sense of stability and well-being.
Tricyclic antidepressants (TCAs) belong to an older class of medications known as first-generation antidepressants. Like SNRIs, TCAs work to block the reuptake of serotonin and noradrenaline. They also affect the activity of acetylcholine—a neurotransmitter involved in memory and learning.
Due to their side effects, TCAs were largely replaced by SSRIs in the U.S. in 1988. Although newer antidepressants are typically the first-choice treatment for depression, the benefits of traditional antidepressants like TCAs may still outweigh the risks for some people.
Like TCAs, monoamine oxidase inhibitors (MAOIs) are first-generation antidepressants that are no longer widely used due to side effects.
MAOIs work to treat depression by reducing, or “inhibiting,” the activity of two enzymes: monoamine oxidase A (MAO-A) and/or monoamine oxidase B (MAO-B). This helps to balance levels of neurotransmitters like serotonin, noradrenaline, and dopamine in order to increase motivation and regulate mood.
Noradrenergic and specific serotoninergic antidepressants (NaSSAs) are sometimes used to treat depression if more common antidepressants aren’t effective.
Sometimes called “atypical antidepressants,” NaSSAs work similarly to tetracyclic antidepressants (TeCAs), which are related to TCAs. In the U.S., the most common NaSSA is Remeron (mirtazapine).
While antidepressants are generally considered safe to use, many people experience some side effects while taking them. Some of the most common side effects of antidepressants include:
For many people, the side effects of antidepressants go away on their own with time. Others find that the benefits of antidepressants outweigh the side effects.
However, some people who take antidepressants experience more persistent or severe adverse effects. For SSRIs and SNRIs, these may include:
Older antidepressants, such as TCAs and MAOIs, have been linked to a number of serious side effects. These include:
Meanwhile, severe side effects of NaSSAs may include:
If you experience any unwanted side effects from antidepressants, talk to your healthcare provider. You may be able to change your dose or switch to a different medication.
In rare cases, antidepressants can increase the risk of suicidal thoughts, especially among people under 25. If you are having thoughts of self-harm or suicide, seek emergency medical help.
If you are experiencing thoughts of self-harm or suicide, call the National Suicide Prevention Lifeline at 988, talk to your healthcare provider, or talk to a mental health professional. If you or someone else is at immediate risk, dial 911.
Antidepressants are primarily used to treat depression. In some cases, they may be prescribed to manage the symptoms of other mental health conditions, such as:
Due to their role in managing chemical imbalances within the brain, antidepressants are also sometimes used to treat physical and neurological conditions. Healthcare providers sometimes prescribe antidepressants to treat the following medical conditions:
Antidepressants are usually effective in treating moderate to severe depression.
Estimates suggest that antidepressants typically reduce depressive symptoms by about 67%. In one study, over 89% of people who were taking antidepressants on a long-term basis reported that their medication had improved their symptoms.
While all FDA-approved antidepressants have been shown to alleviate symptoms of depression, estimates of the effectiveness of each type vary widely. One systematic review and meta-analysis found that Effexor XR, Paxil, Remeron, and Elavil were more effective than Prozac and Luvox on average.
However, many people stop taking antidepressants due to negative side effects (about 44% of people stop taking their medication within just three months). This may lead to relapse or withdrawal symptoms. Around 56% of people who stop taking an antidepressant experience at least some withdrawal symptoms for several weeks or months.
If you plan to stop taking antidepressants, you should only do so with the help and guidance of your healthcare provider. They can help you reduce your dose gradually and safely.
Some people worry about the safety of taking antidepressants during pregnancy. According to the Centers for Disease Control and Prevention (CDC), taking certain SSRIs—especially Prozac or Paxil—early in pregnancy may increase the risk of birth defects. These may include:
Meanwhile, up to 30% of babies exposed to SSRIs during the later stages of pregnancy will develop neonatal adaptation syndrome after birth. Babies with neonatal adaptation syndrome experience symptoms like difficulty breathing, problems with feeding, jitteriness, and irritability.
However, untreated depression can also increase the risks of health complications for both you and your baby. Discuss your options with your healthcare provider if you take antidepressants and are pregnant or trying to become pregnant. They can help you decide whether a lower dose or a different medication may be right for you.
While they are effective for many people, antidepressants aren’t the only way to alleviate symptoms of depression. Here are some other ways you may be able to find relief:
Antidepressants are medicines that are prescribed to treat clinical depression. They may also be used to treat other mental health conditions, as well as insomnia and chronic pain.
The main types of antidepressants are selective serotonin reuptake inhibitors, serotonin and noradrenaline reuptake inhibitors, tricyclic antidepressants, monoamine oxidase inhibitors, and noradrenergic and specific serotoninergic antidepressants.
Antidepressants typically work to regulate mood by increasing the level of certain neurotransmitters—such as serotonin, noradrenaline, and dopamine—in the brain.
Some of the most common side effects of antidepressants include fatigue, sexual side effects, weight gain, dry mouth, dizziness, constipation, and indigestion. Severe side effects from antidepressants, such as abnormal bleeding, heart problems, and high blood pressure, are rare.
If you’re experiencing symptoms of depression, reach out to your healthcare provider. Antidepressants may help boost your mood, reduce fatigue, and improve your overall outlook on life. Your healthcare provider can also suggest other ways to address depression, either alongside medication or as an alternative.
It typically takes antidepressants about four to eight weeks to work. Some people may see improvements earlier. After they start to experience the benefits of antidepressants, most people take them for about six to 12 months under the advice of their healthcare provider.
Researchers haven’t identified a single clear reason as to why antidepressants cause weight gain. Certain antidepressants may affect the body’s metabolism rate. Meanwhile, some antidepressants may increase appetite and cause intense food cravings. Common side effects like fatigue and drowsiness may cause some people to reduce their physical activity.
Centers for Disease Control and Prevention. Antidepressant use among adults: United States, 2015-2018.
Sansone RA, Sansone LA. Serotonin norepinephrine reuptake inhibitors: a pharmacological comparison. Innov Clin Neurosci. 2014;11(3-4):37-42.
American Psychological Association. Reuptake inhibitor.
Edinoff AN, Akuly HA, Hanna TA, et al. Selective serotonin reuptake inhibitors and adverse effects: a narrative review. Neurol Int. 2021;13(3):387-401. doi:10.3390/neurolint13030038
Furukawa TA, Salanti G, Atkinson LZ, et al. Comparative efficacy and acceptability of first-generation and second-generation antidepressants in the acute treatment of major depression: protocol for a network meta-analysis. BMJ Open. 2016;6(7):e010919. doi:10.1136/bmjopen-2015-010919
Harmer CJ, Duman RS, Cowen PJ. How do antidepressants work? New perspectives for refining future treatment approaches. Lancet Psychiatry. 2017;4(5):409-418. doi:10.1016/S2215-0366(17)30015-9
Manzoor S, Hoda N. A comprehensive review of monoamine oxidase inhibitors as anti-Alzheimer's disease agents: a review. Eur J Med Chem. 2020;206:112787. doi:10.1016/j.ejmech.2020.112787
Protti M, Mandrioli R, Marasca C, Cavalli A, Serretti A, Mercolini L. New-generation, non-SSRI antidepressants: drug-drug interactions and therapeutic drug monitoring. Part 2: NaSSAs, NRIs, SNDRIs, MASSAs, NDRIs, and others. Med Res Rev. 2020;40(5):1794-1832. doi:10.1002/med.21671
Kishi T, Iwata N. Meta-analysis of noradrenergic and specific serotonergic antidepressant use in schizophrenia. Int J Neuropsychopharmacol. 2014;17(2):343-354. doi:10.1017/S1461145713000667
NHS. Side effects - antidepressants.
Bala A, Nguyen HMT, Hellstrom WJG. Post-SSRI sexual dysfunction: a literature review. Sex Med Rev. 2018;6(1):29-34. doi:10.1016/j.sxmr.2017.07.002
Scotton WJ, Hill LJ, Williams AC, Barnes NM. Serotonin syndrome: pathophysiology, clinical features, management, and potential future directions. Int J Tryptophan Res. 2019;12:1178646919873925. doi:10.1177/1178646919873925
Wang SM, Han C, Bahk WM, et al. Addressing the side effects of contemporary antidepressant drugs: a comprehensive review. Chonnam Med J. 2018;54(2):101-112. doi:10.4068/cmj.2018.54.2.101
Laporte S, Chapelle C, Caillet P, et al. Bleeding risk under selective serotonin reuptake inhibitor (SSRI) antidepressants: A meta-analysis of observational studies. Pharmacol Res. 2017;118:19-32. doi:10.1016/j.phrs.2016.08.017
Fanelli D, Weller G, Liu H. New serotonin-norepinephrine reuptake inhibitors and their anesthetic and analgesic considerations. Neurol Int. 2021;13(4):497-509. doi:10.3390/neurolint13040049
Shuman M, Chukwu A, Van Veldhuizen N, Miller SA. Relationship between mirtazapine dose and incidence of adrenergic side effects: an exploratory analysis. Ment Health Clin. 2019;9(1):41-47. doi:10.9740/mhc.2019.01.041
Zhang Y, Yang H, Yang S, et al. Antidepressants for bipolar disorder: a meta-analysis of randomized, double-blind, controlled trials. Neural Regen Res. 2013;8(31):2962-2974. doi:10.3969/j.issn.1673-5374.2013.31.009
Mao YM, Zhang MD. Augmentation with antidepressants in schizophrenia treatment: benefit or risk. Neuropsychiatr Dis Treat. 2015;11:701-713. doi:10.2147/NDT.S62266
Timäus C, Meiser M, Bandelow B, et al. Pharmacotherapy of borderline personality disorder: what has changed over two decades? A retrospective evaluation of clinical practice. BMC Psychiatry. 2019;19(1):393. doi:10.1186/s12888-019-2377-z
Tzadok R, Ablin JN. Current and emerging pharmacotherapy for fibromyalgia. Pain Res Manag. 2020;2020:6541798. doi:10.1155/2020/6541798
Everitt H, Baldwin DS, Stuart B, et al. Antidepressants for insomnia in adults. Cochrane Database Syst Rev. 2018;5(5):CD010753. doi:10.1002/14651858.CD010753.pub2
Burch R. Antidepressants for preventive treatment of migraine. Curr Treat Options Neurol. 2019;21(4):18. doi:10.1007/s11940-019-0557-2
Stamoula E, Siafis S, Dardalas I, et al. Antidepressants on multiple sclerosis: a review of in vitro and in vivo models. Front Immunol. 2021;12:677879. doi:10.3389/fimmu.2021.677879
Santarsieri D, Schwartz TL. Antidepressant efficacy and side-effect burden: a quick guide for clinicians. Drugs Context. 2015;4:212290. doi:10.7573/dic.212290
Cartwright C, Gibson K, Read J, Cowan O, Dehar T. Long-term antidepressant use: patient perspectives of benefits and adverse effects. Patient Prefer Adherence. 2016;10:1401-1407. doi:10.2147/PPA.S110632
Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. 2018;391(10128):1357-1366. doi:10.1016/S0140-6736(17)32802-7
Jung WY, Jang SH, Kim SG, et al. Times to discontinue antidepressants over 6 months in patients with major depressive disorder. Psychiatry Investig. 2016;13(4):440-446. doi:10.4306/pi.2016.13.4.440
Davies J, Read J. A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: are guidelines evidence-based? Addict Behav. 2019;97:111-121. doi:10.1016/j.addbeh.2018.08.027
Centers for Disease Control and Prevention. Link between depression treatments and birth defects.
Salisbury AL, O'Grady KE, Battle CL, et al. The roles of maternal depression, serotonin reuptake inhibitor treatment, and concomitant benzodiazepine use on infant neurobehavioral functioning over the first postnatal month. Am J Psychiatry. 2016;173(2):147-157. doi:10.1176/appi.ajp.2015.14080989
Johns Hopkins Medicine. Antidepressants and pregnancy: tips from an expert.
Belvederi Murri M, Ekkekakis P, Magagnoli M, et al. Physical exercise in major depression: reducing the mortality gap while improving clinical outcomes. Front Psychiatry. 2019;9:762. doi:10.3389/fpsyt.2018.00762
Takahashi T, Sugiyama F, Kikai T, et al. Changes in depression and anxiety through mindfulness group therapy in Japan: the role of mindfulness and self-compassion as possible mediators. Biopsychosoc Med. 2019;13:4. doi:10.1186/s13030-019-0145-4
Yeung KS, Hernandez M, Mao JJ, Haviland I, Gubili J. Herbal medicine for depression and anxiety: a systematic review with assessment of potential psycho-oncologic relevance. Phytother Res. 2018;32(5):865-891. doi:10.1002/ptr.6033
Schwartz BS, Glass TA, Pollak J, et al. Depression, its comorbidities and treatment, and childhood body mass index trajectories. Obesity (Silver Spring). 2016;24(12):2585-2592. doi:10.1002/oby.21627
Thank you, {{form.email}}, for signing up.
There was an error. Please try again.